temporomandbular joint disorders
Diagnostic Testno intervention
NCT Number: NCT05402228
120 male and female patients aged between 18-65 years who apply to the outpatient clinic and diagnosed with TMD will be included in the study. Patients will be divided into 3 groups as Muscle Disorders (Group 1), Temporomandibular Joint Disorders (Group 2) and degenerative joint diseas (osteoarthrosis) (Group 3) according to DC/TMD axis I diagnostic criteria.
maximum mouth opening, TMJ sound, pain levels, tinnitus, and dizziness are evaluated.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Kucukcekmece, Turkey (Türkiye)
120 male and female patients aged between 18-65 years who apply to the outpatient clinic and diagnosed with TMD will be included in the study. Patients will be divided into 3 groups as Muscle Disorders (Group 1), Temporomandibular Joint Disorders (Group 2) and degenerative joint diseas (osteoarthrosis) (Group 3) according to DC/TMD axis I diagnostic criteria.
Demographic data of all patients participating in the study will be obtained. Then, physical examination will reveal maximum mouth opening, right and left lateral movement, deflexion, deviation. Accompanying tinnitus, ear fullness and dizziness will be questioned.
All measurements, including maximum mouth opening, and physical examination will be performed with patients sitting upright in an anatomical position in a chair. All measurements will be performed by the same physical therapist with 7 years of experience in TMD.
In the measurement of maximum mouth opening, patients will be asked to open their mouths as wide as possible. The distance between the anterior incisors is measured with the help of a ruler suitable for millimeter measurement. Maximum mouth opening distance is a physical examination method frequently used to determine the motion and function of the jaw joint. Functional mouth opening is accepted as 35-40 mm (12).
For the evaluation of TMJ sound, the TMJ is palpated with the thumb and middle fingers and the sound heard when opening and closing the mesh is noted.
Pain levels are measured using a 10-point visual analog scale (VAS). The presence of bruxism is determined on physical examination based on the presence of abnormal tooth wear, tooth marks in the buccal region, tooth marks on the tongue, and hypertrophy of the masseter muscle.
The sense of fullness in the ear, tinnitus, and dizzyness, which the patients reported themselves, is questioned. The relationship between having TMD, clinical characteristics and dizziness will be evaluated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
no intervention
Time frame: 1 day
maximum mouth opening
Time frame: 1 day
right and left lateral movement, deflexion, and deviation
Time frame: 1 day
the TMJis palpated with the thumb and middle fingers and the sound heard when opening and closing the mesh was noted.
Time frame: 1 day
It is use for evaluate the pain intensity.
Time frame: 1 day
it is determined on physical examination based on the presence of abnormal tooth wear, tooth marks in the buccal region, tooth marks on the tongue, and hypertrophy of the masseter muscle.
Time frame: 1 day
the presence of bruxism, tinnitus and dizzeness
Kanuni Sultan Suleyman Training and Research Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04819087
Craniomandibular Disorders, Ear Diseases
Konya, Karatay, Turkey (Türkiye)
View Trial DetailsNCT07460193
Arthritis, Craniomandibular Disorders
Kütahya, Turkey (Türkiye)
View Trial DetailsNCT05068908
Chronic Pain, Craniomandibular Disorders
Minneapolis, Minnesota, United States
View Trial DetailsNCT07691684
Craniomandibular Disorders, Jaw Diseases
Ramadi, Al Najaf, Iraq
View Trial Details